PARG anticorps (C-Term)
Aperçu rapide pour PARG anticorps (C-Term) (ABIN953994)
Antigène
Voir toutes PARG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 820-849, C-Term
-
Specificité
- This antibody recognizes Human PARG (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 820-849 amino acids from the C-terminal region of human PARG
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PARG
-
Autre désignation
- PARG
-
Sujet
- Poly(ADP-ribose) glycohydrolase (PARG) is the major enzyme responsible for the catabolism of poly(ADP-ribose), a reversible covalent-modifier of chromosomal proteins. The protein is found in many tissues and may be subject to proteolysis generating smaller, active products.Synonyms: PARG99, Poly(ADP-ribose) glycohydrolase
-
Poids moléculaire
- 111110 Da
-
ID gène
- 8505
-
NCBI Accession
- NP_003622
Antigène
-